New Virus Treatment Benefits Breast Cancer Patients

Onlytic virus, in conjugation with systemic chemotherapy, may boost responses in high risk, early stage triple-negative breast cancer.

Related Keywords

Hatem Soliman ,Moffitt Cancer Center ,Triple Negative Breast Cancer ,Nature Medicine ,Breast Cancer Women ,